Study supports precision radiation therapy in lung cancer
Results from a new study led by researchers at The University of Texas MD Anderson Cancer Center support standard use of the more precise intensity-modulated radiotherapy (IMRT) over the alternative 3D-conformal radiotherapy (3D-CRT) for patients with unresectable, locally advanced non-small cell lung cancer (NSCLC). The study, published today in JAMA Oncology, revealed fewer side effects with IMRT, with similar survival outcomes...
MD Anderson’s Institute for Data Science in Oncology establishes internal advisory council to maximize impact
The Institute for Data Science in Oncology (IDSO) at The University of Texas MD Anderson Cancer Center today announced the establishment of...
ASCO: Proton therapy demonstrates advantages in Phase III head and neck cancer trial
ABSTRACT 6006
According to preliminary data from a multi-institution Phase III trial led by researchers at The University of...